{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:34:00Z","timestamp":1785227640153,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-023-00847-x","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T04:20:50Z","timestamp":1707538850000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hemodialysis treatment of vancomycin-induced drug reaction with eosinophilia and systemic symptoms\/drug-induced hypersensitivity syndrome in a patient undergoing peritoneal dialysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Ryunosuke","family":"Mitsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashin","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ei","family":"Kusahana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohkichi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4917-033X","authenticated-orcid":false,"given":"Shintaro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250\u20137. https:\/\/doi.org\/10.1016\/s1085-5629(96)80038-1.","journal-title":"Semin Cutan Med Surg"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588\u201397. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.017.","journal-title":"Am J Med"},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3390\/ijms22042147","volume":"22","author":"F Miyagawa","year":"2021","unstructured":"Miyagawa F, Asada H. Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS). Int J Mol Sci. 2021;22:2417. https:\/\/doi.org\/10.3390\/ijms22042147.","journal-title":"Int J Mol Sci"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","volume":"10","author":"N Hama","year":"2022","unstructured":"Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022;10:1155-1167.e5. https:\/\/doi.org\/10.1016\/j.jaip.2022.02.004.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","volume":"136","author":"CY Ng","year":"2016","unstructured":"Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, et al. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. J Invest Dermatol. 2016;136:1373\u201381. https:\/\/doi.org\/10.1016\/j.jid.2016.02.808.","journal-title":"J Invest Dermatol"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.7859","volume":"312","author":"WH Chung","year":"2014","unstructured":"Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, et al. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA. 2014;312:525\u201334. https:\/\/doi.org\/10.1001\/jama.2014.7859.","journal-title":"JAMA"},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000112926","volume":"216","author":"E Maubec","year":"2008","unstructured":"Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P, et al. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology. 2008;216:200\u20134. https:\/\/doi.org\/10.1159\/000112926.","journal-title":"Dermatology"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/jamadermatol.2022.3541","volume":"158","author":"KG Blumenthal","year":"2022","unstructured":"Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, et al. Risk factors for vancomycin drug reaction with eosinophilia and systemic symptoms syndrome. JAMA Dermatol. 2022;158:1449\u201353. https:\/\/doi.org\/10.1001\/jamadermatol.2022.3541.","journal-title":"JAMA Dermatol"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071\u201380. https:\/\/doi.org\/10.1111\/bjd.12501.","journal-title":"Br J Dermatol."},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","volume":"77","author":"S Sharifzadeh","year":"2021","unstructured":"Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77:275\u201389. https:\/\/doi.org\/10.1007\/s00228-020-03005-9.","journal-title":"Eur J Clin Pharmacol"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809\u201320. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00547.x.","journal-title":"Allergy"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"3968690","DOI":"10.1155\/2016\/3968690","volume":"2016","author":"T Kumar","year":"2016","unstructured":"Kumar T, Teo I, McCormick BB. Systemic toxicity of intraperitoneal vancomycin. Case Rep Nephrol. 2016;2016:3968690. https:\/\/doi.org\/10.1155\/2016\/3968690.","journal-title":"Case Rep Nephrol"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1177\/08968608221080586","volume":"198","author":"D Melis","year":"2017","unstructured":"Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting edge: increased autoimmunity risk in glycogen storage disease type 1b Is associated with a reduced engagement of glycolysis in T cells and an impaired regulatory T cell function. J Immunol. 2017;198:3803\u20138. https:\/\/doi.org\/10.1177\/08968608221080586.","journal-title":"J Immunol"},{"key":"847_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16: e1. https:\/\/doi.org\/10.1038\/gim.2014.128.","journal-title":"Genet Med"},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","volume":"152","author":"MG Kirchhof","year":"2016","unstructured":"Kirchhof MG, Wong A, Dutz JP. Cyclosporine treatment of drug-induced hypersensitivity syndrome. JAMA Dermatol. 2016;152:1254\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2016.2220.","journal-title":"JAMA Dermatol"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2019.02.002","volume":"81","author":"LM Madigan","year":"2019","unstructured":"Madigan LM, Fox LP. Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol. 2019;81:123\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.002.","journal-title":"J Am Acad Dermatol"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1744-9987.2005.00320.x","volume":"9","author":"M Higuchi","year":"2005","unstructured":"Higuchi M, Agatsuma T, Iizima M, Yamazaki Y, Saita T, Ichikawa T, et al. A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange. Ther Apher Dial. 2005;9:412\u20136. https:\/\/doi.org\/10.1111\/j.1744-9987.2005.00320.x.","journal-title":"Ther Apher Dial"},{"key":"847_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12245-023-00511-2","volume":"16","author":"H Oiwa","year":"2023","unstructured":"Oiwa H, Yoshida S, Okada H, Yasunishi M, Kamidani R, Suzuki K, et al. Atypical drug-induced hypersensitivity syndrome with multiple organ failure rescued by combined acute blood purification therapy: a case report. Int J Emerg Med. 2023;16:33. https:\/\/doi.org\/10.1186\/s12245-023-00511-2.","journal-title":"Int J Emerg Med"},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/0896860819889774","volume":"40","author":"E Lam","year":"2020","unstructured":"Lam E, Lien Y, Kraft W, Kraft W, Piraino B, Vozmediano V, et al. Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy. Perit Dial Int. 2020;40:384\u201393. https:\/\/doi.org\/10.1177\/0896860819889774.","journal-title":"Perit Dial Int"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/BF00265928","volume":"42","author":"J B\u00f6hler","year":"1992","unstructured":"B\u00f6hler J, Reetze-Bonorden P, Keller E, Kramer A, Schollmeyer PJ. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes. Eur J Clin Pharmacol. 1992;42:635\u20139. https:\/\/doi.org\/10.1007\/BF00265928.","journal-title":"Eur J Clin Pharmacol"},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.1994.28","volume":"45","author":"TA Pollard","year":"1994","unstructured":"Pollard TA, Lampasona V, Akkerman S, Tom K, Hooks MA, Mullins RE, et al. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis. Kidney Int. 1994;45:232\u20137. https:\/\/doi.org\/10.1038\/ki.1994.28.","journal-title":"Kidney Int"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.clindermatol.2020.04.014","volume":"38","author":"RA Waldman","year":"2020","unstructured":"Waldman RA, Grant-Kels JM. Thinking outside the box: is there a role for extracorporeal blood purification in DRESS syndrome complicated by acute kidney injury? Clin Dermatol. 2020;38:580\u20133. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.04.014.","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"847_CR23","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/491712","volume":"42","author":"MJ Rybak","year":"2006","unstructured":"Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(Suppl 1):S35\u20139. https:\/\/doi.org\/10.1086\/491712.","journal-title":"Clin Infect Dis"},{"key":"847_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PD Li","year":"2022","unstructured":"Li PD, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110\u201353. https:\/\/doi.org\/10.1177\/08968608221080586.","journal-title":"Perit Dial Int"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-023-00847-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:14:18Z","timestamp":1727792058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-023-00847-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s13730-023-00847-x","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"17 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and\/or animal participants"}},{"value":"Informed consent was obtained from the patient for publication of this case report and all accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}